Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280769 · ClinicalTrials.gov registry record · NA
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05280769 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 31 participants.
The verdict
NCT05280769, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out how three different nicotine pouches and participant's own brand of smokeless tobacco affect blood nicotine levels and how participants feel.
Interventions
- OTHER oral nicotine pouch - 2 mg
- OTHER oral nicotine pouch - 4 mg
- OTHER oral nicotine pouch - 8 mg
- OTHER Smokeless tobacco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-08-23 |
| Est. Completion | 2023-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05280769
The ClinicalTrials.gov registry entry for NCT05280769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which oral nicotine pouch - 2 mg is the first listed.
NCT05280769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05280769 about?
NCT05280769 is a clinical study titled "Effects of an Oral Nicotine Product in Smokeless Tobacco Users". The purpose of this research study is to find out how three different nicotine pouches and participant's own brand of smokeless tobacco affect blood nicotine levels and how participants feel.
What is the current status of trial NCT05280769?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-08-23. Estimated completion is 2023-11-28.
What interventions are being tested in trial NCT05280769?
The interventions under investigation include: oral nicotine pouch - 2 mg (OTHER), oral nicotine pouch - 4 mg (OTHER), oral nicotine pouch - 8 mg (OTHER), Smokeless tobacco (OTHER).
Who is sponsoring clinical trial NCT05280769?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.